Vanessa K. Jones
Publications by Year
Research Areas
CAR-T cell therapy research, Glioma Diagnosis and Treatment, Immunotherapy and Immune Responses, Viral Infectious Diseases and Gene Expression in Insects, Cancer Research and Treatments
Most-Cited Works
- → Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1(2024)11 cited
- → Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone(2024)8 cited
- → Single CAR-Dual target: Intracranial Delivery of Anti-PD-L1 CAR T Cells Effectively Eradicates Glioma and Immunosuppressive Cells in the Tumor Microenvironment(2024)1 cited
- → Cell-specific crosstalk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone(2023)1 cited
- → 2008 Striking Twice With One Hit: Enhancing Neurosurgery Through Patient-Derived CAR T-Cell Therapy Against Human Glioblastoma and Tumor Microenvironment via Locoregional and Systemic Infusion, Bolstered by Anti PD-L1 Strategy(2025)
- → Advancing CAR T-Cell Therapy: Simultaneously Attack Tumor and Immunosuppressive Cells in the Tumor Microenvironment(2024)
- → TMOD-45. Immune Competent Glioblastoma Models for Therapeutic Translation(2025)
- → CNSC-16. BIDIRECTIONAL SIGNALING BETWEEN GLIOBLASTOMA AND NEURAL PROGENITORS EXPLORED WITH CELL-SPECIFIC PROTEOMICS RESULTS IN INCREASED TUMOR MALIGNANCY AND ALTERED NEUROGENESIS IN THE SUBVENTRICULAR ZONE(2022)
- → BIOM-15. GLIOBLASTOMA CELLS SHOW ELEVATED CHITINASE 3-LIKE PROTEIN 1 GENE EXPRESSION IN RESPONSE TO HUMAN CEREBROSPINAL FLUID WITH INCREASED MIGRATION AND EPITHELIAL-MESENCHYMAL TRANSITION RELATED ACTIVITY(2022)
- → Abstract 4812: Intracranial delivery of MC9999 CAR T-cell therapy: a novel strategy to simultaneously eliminate GBM tumors and immunosuppressive components in the tumor microenvironment(2025)